TELA Bio, Inc.

TELASEC EDGAR

Surgical & Medical Instruments & Apparatus(DE)CIK: 1561921

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	$41.4M	$29.5M	$18.2M	$15.4M	$8.3M
Gross Profit	$27.0M	$18.8M	$11.2M	$9.3M	$2.9M
Research and Development Expense	$8.9M	$6.7M	$4.3M	$4.2M	$4.3M
Operating Expenses	$66.1M	$48.3M	$36.5M	$28.4M	$20.7M
Operating Income (Loss)	-$39.0M	-$29.5M	-$25.3M	-$19.2M	-$17.8M
Interest Expense	—	$3.6M	$3.6M	$3.6M	$1.8M
Nonoperating Income (Expense)	-$5.3M	-$3.8M	-$3.5M	-$3.3M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$78.0M	$67.9M	$62.5M	$86.5M	$67.9M
Assets, Current	$71.7M	$62.4M	$59.1M	$83.2M	$64.3M
Cash and Cash Equivalents, at Carrying Value	$46.7M	$42.0M	$43.9M	$74.4M	$45.3M
Inventory, Net	$13.2M	$11.8M	$7.7M	$3.9M	$4.6M
Liabilities	$59.2M	$53.5M	$42.4M	$37.4M	$37.0M
Liabilities, Current	$17.0M	$12.4M	$10.6M	$6.6M	$6.7M
Long-term Debt	$40.5M	$39.9M	$31.5M	$30.8M	$30.2M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$40.7M	-$30.4M	-$24.5M	-$25.5M	-$19.9M
Net Cash Provided by (Used in) Investing Activities	-$1.9M	-$627.0K	$9.1M	-$12.0M	-$1.6M
Net Cash Provided by (Used in) Financing Activities	$40.9M	$585.0K	$44.4M	$65.5M	$27.4M
Payments to Acquire Property, Plant, and Equipment	$872.0K	$627.0K	$167.0K	$197.0K	$62.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)